FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.3318
-0.0094 (-2.75%)
At close: Jan 30, 2026, 4:00 PM EST
0.3479
+0.0161 (4.85%)
After-hours: Jan 30, 2026, 7:55 PM EST
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $22.07 million as of January 30, 2026. Its market cap has decreased by -66.54% in one year.
Market Cap
22.07M
Enterprise Value
24.32M
1-Year Change
-66.54%
Ranking
Category
Stock Price
$0.33
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $22.07M, a decrease of -97.67%. That is a compound annual growth rate of -84.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 22.70M | 51.71% |
| Dec 31, 2025 | 14.96M | -78.68% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CollPlant Biotechnologies | 24.02M |
| Genenta Science | 23.11M |
| Vistagen Therapeutics | 22.05M |
| Intensity Therapeutics | 21.96M |
| Neuphoria Therapeutics | 21.62M |
| CASI Pharmaceuticals | 20.96M |
| IO Biotech | 20.87M |
| NanoViricides | 20.81M |